Literature DB >> 1688589

T cell receptor junctional regions and the MHC molecule affect the recognition of antigenic peptides by T cell clones.

S B Sorger1, Y Paterson, P J Fink, S M Hedrick.   

Abstract

Nine independent pigeon cytochrome c-specific T cell clones were analyzed by using a panel of antigenic peptide analogs presented in association with three allelic IE-encoded MHC glycoproteins. Eight of the T cell clones expressed a TCR composed of a unique alpha- and beta-chain amino acid sequence, and concordantly, each of these T cell clones exhibited a unique Ag specificity. This was true for several clones which differed only in TCR V-J junctional regions. Interestingly, for a given clone, the response to some of the peptide analogs depended to a large extent on the allelic form of the presenting MHC molecule. A simple interpretation of these data would suggest that certain positions of the peptide Ag are most important for Ag-MHC molecule interactions, and that these specific interactions can influence the antigenic epitope recognized by the TCR. We suggest that an antigenic peptide binds to an MHC glycoprotein in a distinct way, but may retain a measure of flexibility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688589

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Highly conserved T-cell receptor junctional regions. Evidence for selection at the protein and the DNA level.

Authors:  S B Sorger; S M Hedrick
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.

Authors:  Petra Kleindienst; Thomas Brocker
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

3.  Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.

Authors:  D M Page; J Alexander; K Snoke; E Appella; A Sette; S M Hedrick; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Functional development of the T cell receptor for antigen.

Authors:  Peter J R Ebert; Qi-Jing Li; Johannes B Huppa; Mark M Davis
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.

Authors:  J Shilyansky; M I Nishimura; J R Yannelli; Y Kawakami; L S Jacknin; P Charmley; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.

Authors:  P A Moss; R J Moots; W M Rosenberg; S J Rowland-Jones; H C Bodmer; A J McMichael; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Predicted complementarity determining regions of the T cell antigen receptor determine antigen specificity.

Authors:  C D Katayama; F J Eidelman; A Duncan; F Hooshmand; S M Hedrick
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

8.  The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope.

Authors:  R Wang; Y Wang-Zhu; C R Gabaglia; K Kimachi; H M Grey
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

9.  T cell avidity and tumor recognition: implications and therapeutic strategies.

Authors:  Mark D McKee; Jeffrey J Roszkowski; Michael I Nishimura
Journal:  J Transl Med       Date:  2005-09-20       Impact factor: 5.531

10.  T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.

Authors:  J L Casanova; P Romero; C Widmann; P Kourilsky; J L Maryanski
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.